S 2817
116th Congress
Senate
Health
Asia
Australia
Canada
Department of Health and Human Services
Europe
Executive agency funding and structure
France
Germany
Health care costs and insurance
Health programs administration and funding
Indian social and development programs
Inflation and prices
Italy
Japan
Medicaid
Medical research
Medicare
Netherlands
North America
End Price Gouging for Insulin Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 7, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Nov 7, 2019
Introduced in Senate
Plain-English summary
End Price Gouging for Insulin Act
This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Committees of jurisdiction
1
Cosponsors
1